13F HOLDINGS REPORT
Birchview Capital, LP
Quarter ended Q1 2023 · Filed February 3, 2023 · Accession 0001618205-23-000001
Total Value
$141,566
Positions
57
Other Managers
0
Confidential Omitted
No
Holdings (57)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 727,785 | $52,364 | 36.99% |
| 2 | BIODESIX INC | BDSX | 5,039,633 | $11,591 | 8.19% |
| 3 | NEUROCRINE BIOSCIENCES INC | NBIX | 84,240 | $10,062 | 7.11% |
| 4 | PROTHENA CORP PLC | PRTA | 127,195 | $7,663 | 5.41% |
| 5 | AZIYO BIOLOGICS INC | ELUT | 1,515,184 | $6,440 | 4.55% |
| 6 | QUIDELORTHO CORP | QDEL | 61,306 | $5,252 | 3.71% |
| 7 | OVINTIV INC | OVV | 84,200 | $4,270 | 3.02% |
| 8 | UNITED THERAPEUTICS CORP | UTHR | 15,000 | $4,171 | 2.95% |
| 9 | ACADIA PHARMACEUTICALS INC | ACAD | 249,400 | $3,970 | 2.80% |
| 10 | PHREESIA INC | PHR | 82,700 | $2,676 | 1.89% |
| 11 | HARROW HEALTH INC | HROW | 180,000 | $2,657 | 1.88% |
| 12 | ALBIREO PHARMA INC | 01345P106 | 117,000 | $2,528 | 1.79% |
| 13 | MASIMO CORP | MASI | 15,280 | $2,261 | 1.60% |
| 14 | INHIBRX INC | INBX | 70,448 | $1,736 | 1.23% |
| 15 | FOGHORN THERAPEUTICS INC | FHTX | 264,843 | $1,690 | 1.19% |
| 16 | ACCELERATE DIAGNOSTICS INC | 00430H102 | 2,252,388 | $1,590 | 1.12% |
| 17 | AVEO PHARMACEUTICALS INC | 053588307 | 100,000 | $1,495 | 1.06% |
| 18 | ALKERMES PLC | ALKS | 50,000 | $1,307 | 0.92% |
| 19 | CYTOKINETICS INC | CYTK | 25,000 | $1,146 | 0.81% |
| 20 | ALPHATEC HOLDINGS INC | ATEC | 90,000 | $1,112 | 0.79% |
| 21 | CORCEPT THERAPEUTICS INC | CORT | 50,000 | $1,016 | 0.72% |
| 22 | KARYOPHARM THERAPEUTICS INC | KPTI | 291,332 | $991 | 0.70% |
| 23 | EQUITRANS MIDSTREAM CORPORATIO | 294600101 | 133,050 | $891 | 0.63% |
| 24 | PIONEER NATURAL RESOURCES CO | 723787107 | 3,800 | $868 | 0.61% |
| 25 | DOCGO INC | DCGO | 110,000 | $778 | 0.55% |
| 26 | IMMUNOGEN INC | 45253H101 | 150,000 | $744 | 0.53% |
| 27 | VENTYX BIOSCIENCES INC | 92332V107 | 22,000 | $721 | 0.51% |
| 28 | BLUEBIRD BIO INC | 09609G100 | 98,000 | $678 | 0.48% |
| 29 | APELLIS PHARMACEUTICALS INC | APLS | 12,000 | $621 | 0.44% |
| 30 | HALOZYME THERAPEUTICS INC | HALO | 10,000 | $569 | 0.40% |
| 31 | 2SEVENTY BIO INC | 901384107 | 59,833 | $561 | 0.40% |
| 32 | IVERIC BIO INC | 46583P102 | 25,000 | $535 | 0.38% |
| 33 | SILK ROAD MEDICAL INC | 82710M100 | 10,000 | $529 | 0.37% |
| 34 | ARVINAS INC | ARVN | 15,000 | $513 | 0.36% |
| 35 | SOLENO THERAPEUTICS INC | SLNO | 245,127 | $485 | 0.34% |
| 36 | KINIKSA PHARMACEUTICALS LTD | KNSA | 30,000 | $449 | 0.32% |
| 37 | PROTAGONIST THERAPEUTICS INC | PTGX | 38,000 | $415 | 0.29% |
| 38 | XENON PHARMACEUTICALS INC | XENE | 10,000 | $394 | 0.28% |
| 39 | 10X GENOMICS INC | TXG | 10,000 | $364 | 0.26% |
| 40 | AMICUS THERAPEUTICS INC | FOLD | 28,000 | $342 | 0.24% |
| 41 | KEROS THERAPEUTICS INC | KROS | 7,000 | $336 | 0.24% |
| 42 | SAREPTA THERAPEUTICS INC | SRPT | 2,500 | $324 | 0.23% |
| 43 | XENCOR INC | XNCR | 12,300 | $320 | 0.23% |
| 44 | KALVISTA PHARMACEUTICALS INC | KALV | 40,000 | $270 | 0.19% |
| 45 | NEKTAR THERAPEUTICS | NKTR | 118,000 | $267 | 0.19% |
| 46 | CULLINAN MANAGEMENT INC | CGEM | 25,114 | $265 | 0.19% |
| 47 | BIOCRYST PHARMACEUTICALS INC | BCRX | 20,000 | $230 | 0.16% |
| 48 | INFLARX NV | IFRX | 70,000 | $217 | 0.15% |
| 49 | G1 THERAPEUTICS INC | 3621LQ109 | 40,000 | $217 | 0.15% |
| 50 | GOSSAMER BIO INC | GOSS | 99,088 | $215 | 0.15% |
| 51 | STOKE THERAPEUTICS INC | STOK | 15,000 | $138 | 0.10% |
| 52 | CONCERT PHARMACEUTICALS INC | 206022105 | 20,000 | $117 | 0.08% |
| 53 | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | BHVN | 7,365 | $102 | 0.07% |
| 54 | ANGION BIOMEDICA CORP | ANGI | 54,392 | $44 | 0.03% |
| 55 | YIELD10 BIOSCIENCE INC | 98585K102 | 18,750 | $31 | 0.02% |
| 56 | ASPIRA WOMEN'S HEALTH INC | 04537Y109 | 60,070 | $20 | 0.01% |
| 57 | SIENTRA INC | 82621J105 | 40,000 | $8 | 0.01% |